Hormone-replacement therapy and lobular cancers: new deals and old myths

References

• Rossouw JE, Anderson GL, Prentice RL et al.; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA288, 321–333 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR et al.; Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA291, 1701–1712 (2004).
   PubMed Web of Science ®Google Scholar
• Beral V; Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet362419–427 (2003).
   PubMed Web of Science ®Google Scholar
• Li CI, Anderson BO, Daling JR, Moe RE. Trend in incidence rates of invasive lobular and ductal breast carcinoma. JAMA289, 1421–1424 (2003).
   PubMed Web of Science ®Google Scholar
• Newcomer LM, Newcomb PA, Daling JR, Yasui Y, Potter JD. Post-menopausal hormone use and risk of breast cancer by histologic type (United States). Cancer Causes Control14, 225–233 (2003).
   PubMed Web of Science ®Google Scholar
• Daling JR, Malone KE, Doody DR et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer95, 2455–2464 (2002).
   PubMed Web of Science ®Google Scholar
• Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. JAMA287, 734–741 (2002).
   PubMed Web of Science ®Google Scholar
• Newcomb PA, Titus-Ernstoff L, Egan KM et al. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol. Biomarkers Prev.11, 593–600 (2002).
   PubMed Web of Science ®Google Scholar
• Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer88, 2561–2569 (2000).
   PubMed Web of Science ®Google Scholar
• Biglia N, Sgro L, Defabiani E et al. The influence of hormone replacement therapy on the pathology of breast cancer. Eur. J. Surg. Oncol.31, 467–472 (2005).
   Google Scholar
• Li CI, Anderson BO, Verkooijen HM et al. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int. J. Cancer104, 778–781 (2003).
   Google Scholar
• Verkooijen HM, Koot VC, Fioretta G et al. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Breast Cancer Res. Treat.107(3), 389–395 (2008).
   PubMed Web of Science ®Google Scholar
• Cutuli B, Cottu PH, Guastalla JP, Mechin H, Costa A, Jourdan R. A French national survey on infiltrating breast cancer: analysis of clinico–pathological features and treatment modalities in 1159 patients. Breast Cancer Res. Treat.95(1), 55–64 (2006).
   PubMed Web of Science ®Google Scholar
• Reeves GK, Beral V, Green J, Gathani T, Bull D; Million Women Study Collaborators. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol.7, 910–918 (2006).
   PubMed Web of Science ®Google Scholar
• Biglia N, Mariani L, Sgro L, Mininanni P, Moggio G, Sismondi P. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment. Endocr. Relat. Cancer14(3), 549–567 (2007).
   Google Scholar
• Magnusson C, Persson I, Adami HO. More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Nat. Cancer Inst.92, 1183–1184 (2000).
   Web of Science ®Google Scholar
• Li CI, Malone KE, Porter PL et al. Relationships between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA289, 3254–3263 (2003).
   PubMed Web of Science ®Google Scholar
• Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW. Infiltrating lobular carcinoma of the breast. Histopathology6, 149–161 (1982).
   PubMed Web of Science ®Google Scholar
• Korhonen T, Huhtala H, Holli K. A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res. Treat.85, 23–29 (2004).
   Google Scholar
• Evans WP, Warren Burhenne LJ, Laurie L, O’Shaughnessy KF, Castellino RA. Invasive lobular carcinoma of the breast: mammographic characteristics and computer-aided detection. Radiology225, 182–189 (2002).
   Google Scholar
• Rissanen T, Tikkakoski T, Autio AL, Apaja-Sarkkinen M. Ultrasonography of invasive lobular breast carcinoma. Acta Radiologica39, 285–291 (1998).
   Google Scholar
• Helvie MA, Paramagul C, Oberman HA, Adler DD. Invasive lobular carcinoma: imaging features and clinical detection. Inv. Radiol.28, 202–207 (1993).
   Google Scholar
• Kneeshaw PJ, Turnbull LW, Smith, Drew PJ. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur. J. Surg. Oncol.29, 32–37 (2003).
   Google Scholar
• Boetes C, Veltman J, Van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular carcinoma. Breast Cancer Res. Treat.36, 31–37 (2004).
   Google Scholar
• Quan ML, Sclafani L, Heerdt S, Fey JV, Morris EA, Borgen PI. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann. Surg. Oncol.10, 1048–1053 (2003).
   Google Scholar
• Bedrosian I, Mick R, Orel SG et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer98, 468–473 (2003).
   PubMed Web of Science ®Google Scholar
• Sardanelli F, Giuseppetti G, Panizza P et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole breast pathologic examination as a gold standard. Am. J. Roentgenol.183, 1149–1157 (2004).
   PubMed Web of Science ®Google Scholar
• Mann RM, Veltman J, Barentsz JO, Wobbes T, Blickman JG, Boetes C. The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur. J. Surg. Oncol.34(2), 135–142 (2008).
   Web of Science ®Google Scholar
• Morrow M. Magnetic resonance imaging in breast cancer: one step forward, two steps back? JAMA292(22), 2779–2780 (2004).
   Google Scholar
• Hwang S, Ioffe O, Lee I, Waisman J, Cangiarella J, Simsir A. Cytologic diagnosis of invasive lobular carcinoma: factors associated with negative and equivocal diagnoses. Diag. Cytopathol.31, 87–93 (2004).
   Google Scholar
• Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. Infiltrating lobular carcinoma – a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast13, 389–396 (2004).
   Google Scholar
• Menet E, Becette V, Briffod M. Cytologic diagnosis of lobular carcinoma of the breast: experience with 555 patients in the Rene Huguenin Cancer Center. Cancer114(2), 111–117 (2008).
   Google Scholar
• Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characterictcs and clinical outcome. Breast Cancer Res.6, 149–156 (2004).
   PubMed Web of Science ®Google Scholar
• Mersin H, Yildirim E, Gulben K, Berberoglu U. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur. J. Surg. Oncol.29390–395 (2003).
   PubMedGoogle Scholar
• Pappo I, Meirshon I, Karni T et al. The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers. Ann. Surg. Oncol.11, 52–58 (2004).
   Google Scholar
• Santiago RJ, Harris EE, Qinj L, Hwang WT, Solin LJ. Similar long-term results of breast –conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience. Cancer103, 2447–2554 (2005).
   Google Scholar
• Chagpar A, Martin II RCG, Hagerndoorn LJ, Chao BSC, McMasters KM. Lumpectomy margins are affected by tumour size and histologic subtype but not by biopsy technique. Am. J. Surg.188, 399–402 (2004).
   Google Scholar
• Fleming FJ, Hill AD, Mc Dermott EW, O’Doherty A, O’Higgins NJ, Quinn CM. Intraoperative margin assessment and reexcision rate in breast conserving surgery. Eur. J. Surg. Oncol.30, 233–237 (2004).
   Google Scholar
• Mathieu MC, Rouzier R, Llombart-Cussac A et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur. J. Cancer40, 342–351 (2004).
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Gonzalez-Angulo A, Sneige N et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J. Clin. Oncol.23, 41–48 (2005).
   PubMed Web of Science ®Google Scholar
• Tubiana-Hulin M, Stevens D, Lasry S et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann. Oncol.17, 1228–1233 (2006).
   Google Scholar
• Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma. A report from the National Cancer Data Base. Ann. Surg.242, 281–289 (2005).
   PubMedGoogle Scholar
• Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann. Surg. Oncol.20, 545–550 (1997).
   Google Scholar
• Classe JM, Loussouarn D, Campion L et al. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study. Cancer100, 935–941 (2004).
   PubMed Web of Science ®Google Scholar
• Chan SW, LaVigne KA, Port ER et al. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer? Ann. Surg.247(1), 143–149 (2008).
   Google Scholar
• Gupta A, Deshpande CG, Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer97, 2341–2347 (2003).
   PubMed Web of Science ®Google Scholar
• Creager AJ, Geisinger KR, Perrier ND et al. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann. Surg.239(1), 61–66 (2004).
   PubMed Web of Science ®Google Scholar
• Cox C, Centeno B, Dickson D. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer105, 13–20 (2005).
   PubMedGoogle Scholar